Clinical insights

Perspectives and resources from knowledgeable industry experts to help you stay informed on the impact of emerging therapies.

In recent years, groundbreaking advancements in oncology care have demonstrated exciting potential to dramatically improve outcomes. Innovative new treatments in precision oncology, such as immunotherapy, gene therapy and molecular-targeted therapy are changing the landscape. And, as many of these therapies will be delivered in the community practice setting, these advancements will transform community oncology care for the future. Additionally, as more biosimilars gain approval in the US, the potential for these treatments to drastically reduce the cost of care will also have a significant impact.

VitalSource? GPO is committed to helping you solve your greatest challenges and providing resources to help you understand the ever-evolving oncology field. Our experts are here to offer their perspectives on emerging treatments, help you understand the reimbursement and practice management implications and help you stay informed, so that you can focus on developing the right treatment plan for your patients.

Sign up

Connect with us to receive monthly Industry Insights in your inbox.

Practice name

Area of interest

GPO membership and pricing

Training and consultative support

Reimbursement solutions

Business development solutions

Clinical solutions and expertise

Permission to communicate

Yes, I would like to learn more about Cardinal Health’s products and services by email. I can withdraw my consent or change my preferences by visiting Update Preferences. Visit Privacy Policy for more information about Cardinal Health’s privacy practices.

Addressing the impact of COVID-19

In a recent article published by OncLive, Amy Valley, PharmD, Vice President, Product and Solutions Marketing, Cardinal Health Specialty Solutions, explores some of the ways community-based oncologists are addressing the impact of the COVID-19 pandemic on their practices.

New research opportunity

Cardinal Health Specialty Solutions is excited to launch our Practice Research Network (PRN), a new opportunity for community oncology practices.

Older patient standing in front of female doctor smiling.

ASCO 2020

While this year’s ASCO meeting was virtual, it still featured many promising abstracts across multiple disease states, bringing forth exciting treatment options and practice-changing implications. Clinical experts from Cardinal Health Specialty Solutions summarized the most impactful findings for your practice here.

Real-World Evidence (RWE) and FDA Approval

Experts from Cardinal Health Specialty Solutions have published five examples of RWE being submitted in support of the FDA approvals of original or supplementary indications for oncology drugs.

Biosimilar adoption

In this biosimilars update, Cardinal Health’s Vice President of Biosimilars, Sonia Oskouei, PharmD, shares new data indicating that biosimilar uptake is beginning to increase among oncologists and discusses the barriers that continue to affect widespread adoption.

Oncology Insights June 2020

Mounting clinical evidence shows social determinants of health (SDOH) are equally, if not more important to driving health outcomes than a patient’s genetics. In the latest edition of Oncology Insights, oncologists nationwide shared their perspectives on the impact of SDOH on their patients and how they are managing these factors in their practice.